Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Antimicrob Agents Chemother. 2011 Feb;55(2):895-903. doi: 10.1128/AAC.01303-10. Epub 2010 Nov 15.
Individual variation in response to antiretroviral therapy is well-known, but it is not clear if demographic characteristics such as gender, age, and ethnicity are responsible for the variation. To optimize anti-HIV therapy and guide antiretroviral drug discovery, determinants that cause variable responses to therapy need to be evaluated. We investigated the determinants of intracellular concentrations of nucleoside analogs using peripheral blood mononuclear cells from 40 healthy donors. We observed individual differences in the concentrations of the intracellular nucleoside analogs; the mean concentrations of the triphosphate metabolite of ethynylstavudine (4'-Ed4T), zidovudine (AZT), and lamivudine (3TC) were 0.71 pmol/10(6) cells (minimum and maximum, 0.10 and 3.00 pmol/10(6) cells, respectively), 0.88 pmol/10(6) cells (minimum and maximum, 0.10 and 15.18 pmol/10(6) cells, respectively), and 1.70 pmol/10(6) cells (minimum and maximum, 0.20 and 7.73 pmol/10(6) cells, respectively). Gender and ethnicity had no effect on the concentration of 4'-Ed4T and 3TC metabolites. There was a trend for moderation of the concentrations of AZT metabolites by gender (P = 0.17 for gender·metabolite concentration). We observed variability in the activity and expression of cellular kinases. There was no statistically significant correlation between thymidine kinase 1 (TK-1) activity or expression and thymidine analog metabolite concentrations. The correlation between the activity of deoxycytidine kinase (dCK) and the 3TC monophosphate metabolite concentration showed a trend toward significance (P = 0.1). We observed an inverse correlation between the multidrug-resistant protein 2 (MRP2) expression index and the concentrations of AZT monophosphate, AZT triphosphate, and total AZT metabolites. Our findings suggest that the observed variation in clinical response to nucleoside analogs may be due partly to the individual differences in the intracellular concentrations, which in turn may be affected by the cellular kinases involved in the phosphorylation pathway and ATP-binding cassette (ABC) transport proteins.
个体对抗逆转录病毒治疗的反应存在差异,这是众所周知的,但目前尚不清楚性别、年龄和种族等人口统计学特征是否是导致这种差异的原因。为了优化抗 HIV 治疗并指导抗逆转录病毒药物的发现,需要评估导致治疗反应个体差异的决定因素。我们使用 40 名健康供体的外周血单个核细胞来研究核苷类似物的细胞内浓度的决定因素。我们观察到细胞内核苷类似物浓度存在个体差异;乙炔基司他夫定(4'-Ed4T)、齐多夫定(AZT)和拉米夫定(3TC)三磷酸代谢物的平均浓度分别为 0.71 pmol/10(6) 个细胞(最低和最高值分别为 0.10 和 3.00 pmol/10(6) 个细胞)、0.88 pmol/10(6) 个细胞(最低和最高值分别为 0.10 和 15.18 pmol/10(6) 个细胞)和 1.70 pmol/10(6) 个细胞(最低和最高值分别为 0.20 和 7.73 pmol/10(6) 个细胞)。性别和种族对 4'-Ed4T 和 3TC 代谢物浓度没有影响。AZT 代谢物浓度存在性别调节的趋势(性别与代谢物浓度的相关性 P=0.17)。我们观察到细胞激酶的活性和表达存在变异性。胸苷激酶 1(TK-1)活性或表达与胸苷类似物代谢物浓度之间没有统计学显著相关性。脱氧胞苷激酶(dCK)活性与 3TC 单磷酸盐代谢物浓度之间的相关性呈显著趋势(P=0.1)。我们观察到多药耐药蛋白 2(MRP2)表达指数与 AZT 单磷酸盐、AZT 三磷酸盐和总 AZT 代谢物浓度呈负相关。我们的研究结果表明,观察到的核苷类似物临床反应的差异可能部分归因于细胞内浓度的个体差异,而这反过来又可能受到参与磷酸化途径的细胞激酶和三磷酸腺苷结合盒(ABC)转运蛋白的影响。